Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 12, 2017

Issue release date: December 2017

Add all to MyReading List
 
733

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:733-738 (DOI:10.1159/000485484)
Free Access
741

Acknowledgement to Reviewers

Oncol Res Treat 2017;40:741-743 (DOI:10.1159/000485229)
Editorial
744

Oncological Rehabilitation and Cancer Survivorship

Rick O. · Langer T.
Oncol Res Treat 2017;40:744 (DOI:10.1159/000485188)
Free Access
Review Article
746

Late Effects and Long-Term Follow-Up after Cancer in Childhood

Langer T. · Grabow D. · Steinmann D. · Wörmann B. · Calaminus G.
Oncol Res Treat 2017;40:746-750 (DOI:10.1159/000484936)
752

Family-Oriented Rehabilitation (FOR) and Rehabilitation of Adolescents and Young Adults (AYA) in Pediatric Oncology

Krauth K.A.
Oncol Res Treat 2017;40:752-758 (DOI:10.1159/000484609)
760

Return to Work of Cancer Survivors

Seifart U. · Schmielau J.
Oncol Res Treat 2017;40:760-763 (DOI:10.1159/000485079)
764

Rehabilitation of Cancer Survivors with Long-Term Toxicities

Schmielau J. · Rick O. · Reuss-Borst M. · Kalusche-Bontemps E.-M. · Steimann M.
Oncol Res Treat 2017;40:764-771 (DOI:10.1159/000485187)
772

Oncological Rehabilitation

Rick O. · Dauelsberg T. · Kalusche-Bontemps E.-M.
Oncol Res Treat 2017;40:772-777 (DOI:10.1159/000481709)
Editor's Choice - Free Access
Original Article
778

Adjuvant Radiotherapy in High-Risk Squamous Cell Carcinoma of the Vulva: A Two-Institutional Italian Experience

Laliscia C. · Fabrini M.G. · Cafaro I. · Barcellini A. · Baldaccini D. · Miniati M. · Parietti E. · Morganti R. · Paiar F. · Gadducci A.
Oncol Res Treat 2017;40:778-783 (DOI:10.1159/000479876)
784

Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices

Chakupurakal G. · Feiten S. · Burkhard O. · Reiser M. · Ehscheidt P. · Weide R.
Oncol Res Treat 2017;40:784-788 (DOI:10.1159/000480016)
789

The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue Subscale): Validity and Reliability of the Iranian Version

Meysami A. · Yari H. · Haghighat S. · Montazeri A.
Oncol Res Treat 2017;40:789-793 (DOI:10.1159/000479588)
 
794

Society Bulletins

Oncol Res Treat 2017;40:794-797 (DOI:10.1159/000485364)
PharmaForum
799

Carfilzomib. Überlebensvorteil beim multiplen Myelom in der Rezidivsituation

Oncol Res Treat 2017;40:799 (DOI:10.1159/000485479)
MyKarger login required
Free Access
800

Dasatinib bei chronischer myeloischer Leukämie. Retrospektive Analysen unterstreichen Vorteil gegenüber Imatinib

Oncol Res Treat 2017;40:800-801 (DOI:10.1159/000485480)
MyKarger login required
Free Access
802

Fortgeschrittene gastrointestinale Tumoren. Ramucirumab: Prognostische Vorteile für vorbehandelte Patienten

Oncol Res Treat 2017;40:802-803 (DOI:10.1159/000485481)
MyKarger login required
Free Access
 
805

PharmaNews

Oncol Res Treat 2017;40:805 (DOI:10.1159/000485482)
MyKarger login required
Free Access
806

PharmaNews

Oncol Res Treat 2017;40:806-810 (DOI:10.1159/000485483)
MyKarger login required
Free Access
812

Meetings and Conferences

Oncol Res Treat 2017;40:812-814 (DOI:10.1159/000485365)
Free Access
816

Contents Vol. 40, 2017

Oncol Res Treat 2017;40:816-820 (DOI:10.1159/000485478)
Free Access